Featured Resources

Introducing: LifeScienceXchange

Patients are counting on your R&D community for the next wave of life-saving medicines.

LifeScienceXchange is the catalyst: a platform for leaders from diverse life science disciplines to connect, learn and collaborate, so that together we bring new treatments to patients faster, sustainably and at scale.

Providing actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format.

It will help you understand trends, benchmark your work, inform strategy and ultimately get your new treatments to patients, faster.

Precision Medicine on LifeScienceXchange provides the events and channels for R&D to unlock human data for precise, patient-centric solutions.

LSX Logo - Better Patient Slogan

Learn faster and put new ideas to work

Market Insights unlock key learnings and actionable ideas from our industry-leading live events. We’ve cut and curated more than 6,000 hours of live recordings into quick-watch cuts, so you can get straight to the moments that matter.

Innovate sooner and benchmark success

Our Technology Showcases give you first sight of the breakthroughs driving our industry. We put you in touch with new developments and vendor success stories, so you can understand the tech, connect with the innovators and benchmark your work against the best

Learn and share ideas with industry leaders

Our Thought Leadership opportunities put you at the heart of the conversations accelerating life sciences R&D today. Hear interviews and presentations with key opinion leaders each month — and join the conversation by putting your questions to them live.

Get the full picture faster

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. Each week we identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture.

Clinical Diagnostics

AI Analysis of Patient Serum Presents Promising New Lyme Disease Diagnosis Tool

The AI-enabled immunological approach aims to bring accurate diagnoses faster and sooner after potential infection.
Personalised Medicine

Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy

SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.
Biomarker Discovery & Development

Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma

The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.
NGS Bioinformatics

Novel Proteomics Biomarkers Show Potential for TB Lateral Flow Test

Earlier diagnosis of tuberculosis using an easy to use proteomic panel could save millions of lives from the disease.
Liquid Biopsies

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.
Spatial Analysis

The Dawn and Future of Spatial Transcriptomics

Adding positional context to the transcriptomics techniques was a breakthrough that would beckon in a new age of biopsy analysis. Now, integration with AI is the latest transformational addition to the field.
Regulatory

Avicenna.AI Algorithms Pass EU Medical Devices Regulations

Compliance with MDR 2017/745 medical device regulation is a critical step toward European Union CE-mark authorisation.
Personalised Medicine

Life Science Players Join €23m European Project for Precision Medicine, PRECISEU

The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.
Biomarker Discovery & Development

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Clinical Diagnostics

Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®

On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Liquid Biopsies

Feinstein Institutes Links Blood Biomarkers to Psychosis in Alzheimer's Patients

The global aging population means that rates of Alzheimer's disease are expected to reach 14 million patients by 2060, many of whom will experience psychosis.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery